Molecular docking, pharmacokinetic studies, and in vivo pharmacological study of indole derivative 2-(5-methoxy-2-methyl-1H-indole-3-yl)-N′-[(E)-(3-nitrophenyl) methylidene] acetohydrazide as a promising chemoprotective agent against cisplatin induced organ damage
Abstract Cisplatin is an efficient anticancer drug against various types of cancers however, its usage involves side effects. We investigated the mechanisms of action of indole derivative, 2-(5-methoxy-2-methyl-1H-indol-3-yl)-N'-[(E)-(3-nitrophenyl) methylidene] acetohydrazide (MMINA) against a...
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8cdddadb299a44c6b6bde347ea84f9bd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:8cdddadb299a44c6b6bde347ea84f9bd |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:8cdddadb299a44c6b6bde347ea84f9bd2021-12-02T16:31:07ZMolecular docking, pharmacokinetic studies, and in vivo pharmacological study of indole derivative 2-(5-methoxy-2-methyl-1H-indole-3-yl)-N′-[(E)-(3-nitrophenyl) methylidene] acetohydrazide as a promising chemoprotective agent against cisplatin induced organ damage10.1038/s41598-021-84748-y2045-2322https://doaj.org/article/8cdddadb299a44c6b6bde347ea84f9bd2021-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-84748-yhttps://doaj.org/toc/2045-2322Abstract Cisplatin is an efficient anticancer drug against various types of cancers however, its usage involves side effects. We investigated the mechanisms of action of indole derivative, 2-(5-methoxy-2-methyl-1H-indol-3-yl)-N'-[(E)-(3-nitrophenyl) methylidene] acetohydrazide (MMINA) against anticancer drug (cisplatin) induced organ damage using a rodent model. MMINA treatment reversed Cisplatin-induced NO and malondialdehyde (MDA) augmentation while boosted the activity of glutathione peroxidase (GPx), and superoxide dismutase (SOD). The animals were divided into five groups (n = 7). Group1: Control (Normal) group, Group 2: DMSO group, Group 3: cisplatin group, Group 4: cisplatin + MMINA group, Group 5: MMINA group. MMINA treatment normalized plasma levels of biochemical enzymes. We observed a significant decrease in CD4+COX-2, STAT3, and TNF-α cell population in whole blood after MMINA dosage. MMINA downregulated the expression of various signal transduction pathways regulating the genes involved in inflammation i.e. NF-κB, STAT-3, IL-1, COX-2, iNOS, and TNF-α. The protein expression of these regulatory factors was also downregulated in the liver, kidney, heart, and brain. In silico docking and dynamic simulations data were in agreement with the experimental findings. The physiochemical properties of MMINA predicted it as a good drug-like molecule and its mechanism of action is predictably through inhibition of ROS and inflammation.Suhail RazakTayyaba AfsarNousheen BibiMahmoud AbulmeatyWajhul QamarAli AlmajwalAnam InamDara Al DisiMaria ShabbirMashooq Ahmad BhatNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-23 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Suhail Razak Tayyaba Afsar Nousheen Bibi Mahmoud Abulmeaty Wajhul Qamar Ali Almajwal Anam Inam Dara Al Disi Maria Shabbir Mashooq Ahmad Bhat Molecular docking, pharmacokinetic studies, and in vivo pharmacological study of indole derivative 2-(5-methoxy-2-methyl-1H-indole-3-yl)-N′-[(E)-(3-nitrophenyl) methylidene] acetohydrazide as a promising chemoprotective agent against cisplatin induced organ damage |
description |
Abstract Cisplatin is an efficient anticancer drug against various types of cancers however, its usage involves side effects. We investigated the mechanisms of action of indole derivative, 2-(5-methoxy-2-methyl-1H-indol-3-yl)-N'-[(E)-(3-nitrophenyl) methylidene] acetohydrazide (MMINA) against anticancer drug (cisplatin) induced organ damage using a rodent model. MMINA treatment reversed Cisplatin-induced NO and malondialdehyde (MDA) augmentation while boosted the activity of glutathione peroxidase (GPx), and superoxide dismutase (SOD). The animals were divided into five groups (n = 7). Group1: Control (Normal) group, Group 2: DMSO group, Group 3: cisplatin group, Group 4: cisplatin + MMINA group, Group 5: MMINA group. MMINA treatment normalized plasma levels of biochemical enzymes. We observed a significant decrease in CD4+COX-2, STAT3, and TNF-α cell population in whole blood after MMINA dosage. MMINA downregulated the expression of various signal transduction pathways regulating the genes involved in inflammation i.e. NF-κB, STAT-3, IL-1, COX-2, iNOS, and TNF-α. The protein expression of these regulatory factors was also downregulated in the liver, kidney, heart, and brain. In silico docking and dynamic simulations data were in agreement with the experimental findings. The physiochemical properties of MMINA predicted it as a good drug-like molecule and its mechanism of action is predictably through inhibition of ROS and inflammation. |
format |
article |
author |
Suhail Razak Tayyaba Afsar Nousheen Bibi Mahmoud Abulmeaty Wajhul Qamar Ali Almajwal Anam Inam Dara Al Disi Maria Shabbir Mashooq Ahmad Bhat |
author_facet |
Suhail Razak Tayyaba Afsar Nousheen Bibi Mahmoud Abulmeaty Wajhul Qamar Ali Almajwal Anam Inam Dara Al Disi Maria Shabbir Mashooq Ahmad Bhat |
author_sort |
Suhail Razak |
title |
Molecular docking, pharmacokinetic studies, and in vivo pharmacological study of indole derivative 2-(5-methoxy-2-methyl-1H-indole-3-yl)-N′-[(E)-(3-nitrophenyl) methylidene] acetohydrazide as a promising chemoprotective agent against cisplatin induced organ damage |
title_short |
Molecular docking, pharmacokinetic studies, and in vivo pharmacological study of indole derivative 2-(5-methoxy-2-methyl-1H-indole-3-yl)-N′-[(E)-(3-nitrophenyl) methylidene] acetohydrazide as a promising chemoprotective agent against cisplatin induced organ damage |
title_full |
Molecular docking, pharmacokinetic studies, and in vivo pharmacological study of indole derivative 2-(5-methoxy-2-methyl-1H-indole-3-yl)-N′-[(E)-(3-nitrophenyl) methylidene] acetohydrazide as a promising chemoprotective agent against cisplatin induced organ damage |
title_fullStr |
Molecular docking, pharmacokinetic studies, and in vivo pharmacological study of indole derivative 2-(5-methoxy-2-methyl-1H-indole-3-yl)-N′-[(E)-(3-nitrophenyl) methylidene] acetohydrazide as a promising chemoprotective agent against cisplatin induced organ damage |
title_full_unstemmed |
Molecular docking, pharmacokinetic studies, and in vivo pharmacological study of indole derivative 2-(5-methoxy-2-methyl-1H-indole-3-yl)-N′-[(E)-(3-nitrophenyl) methylidene] acetohydrazide as a promising chemoprotective agent against cisplatin induced organ damage |
title_sort |
molecular docking, pharmacokinetic studies, and in vivo pharmacological study of indole derivative 2-(5-methoxy-2-methyl-1h-indole-3-yl)-n′-[(e)-(3-nitrophenyl) methylidene] acetohydrazide as a promising chemoprotective agent against cisplatin induced organ damage |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/8cdddadb299a44c6b6bde347ea84f9bd |
work_keys_str_mv |
AT suhailrazak moleculardockingpharmacokineticstudiesandinvivopharmacologicalstudyofindolederivative25methoxy2methyl1hindole3ylne3nitrophenylmethylideneacetohydrazideasapromisingchemoprotectiveagentagainstcisplatininducedorgandamage AT tayyabaafsar moleculardockingpharmacokineticstudiesandinvivopharmacologicalstudyofindolederivative25methoxy2methyl1hindole3ylne3nitrophenylmethylideneacetohydrazideasapromisingchemoprotectiveagentagainstcisplatininducedorgandamage AT nousheenbibi moleculardockingpharmacokineticstudiesandinvivopharmacologicalstudyofindolederivative25methoxy2methyl1hindole3ylne3nitrophenylmethylideneacetohydrazideasapromisingchemoprotectiveagentagainstcisplatininducedorgandamage AT mahmoudabulmeaty moleculardockingpharmacokineticstudiesandinvivopharmacologicalstudyofindolederivative25methoxy2methyl1hindole3ylne3nitrophenylmethylideneacetohydrazideasapromisingchemoprotectiveagentagainstcisplatininducedorgandamage AT wajhulqamar moleculardockingpharmacokineticstudiesandinvivopharmacologicalstudyofindolederivative25methoxy2methyl1hindole3ylne3nitrophenylmethylideneacetohydrazideasapromisingchemoprotectiveagentagainstcisplatininducedorgandamage AT alialmajwal moleculardockingpharmacokineticstudiesandinvivopharmacologicalstudyofindolederivative25methoxy2methyl1hindole3ylne3nitrophenylmethylideneacetohydrazideasapromisingchemoprotectiveagentagainstcisplatininducedorgandamage AT anaminam moleculardockingpharmacokineticstudiesandinvivopharmacologicalstudyofindolederivative25methoxy2methyl1hindole3ylne3nitrophenylmethylideneacetohydrazideasapromisingchemoprotectiveagentagainstcisplatininducedorgandamage AT daraaldisi moleculardockingpharmacokineticstudiesandinvivopharmacologicalstudyofindolederivative25methoxy2methyl1hindole3ylne3nitrophenylmethylideneacetohydrazideasapromisingchemoprotectiveagentagainstcisplatininducedorgandamage AT mariashabbir moleculardockingpharmacokineticstudiesandinvivopharmacologicalstudyofindolederivative25methoxy2methyl1hindole3ylne3nitrophenylmethylideneacetohydrazideasapromisingchemoprotectiveagentagainstcisplatininducedorgandamage AT mashooqahmadbhat moleculardockingpharmacokineticstudiesandinvivopharmacologicalstudyofindolederivative25methoxy2methyl1hindole3ylne3nitrophenylmethylideneacetohydrazideasapromisingchemoprotectiveagentagainstcisplatininducedorgandamage |
_version_ |
1718383886671544320 |